Literature DB >> 17031517

Classification of surgical procedures for epidemiologic assessment of sporadic Creutzfeldt-Jakob disease transmission by surgery.

J de Pedro-Cuesta1, M J Bleda, A Rábano, M Cruz, H Laursen, K Mølbak, A Siden.   

Abstract

BACKGROUND: In this preparatory phase of a case-control study, we propose and evaluate a new tool for classifying surgical procedures (SPs) in categories useful for epidemiologic research on surgical transmission of sporadic Creutzfeldt-Jakob disease (sCJD).
METHODS: All SPs reported to the Swedish National Hospital Discharge Registry in the period 1974-2002, and undergone by 212 Swedish patients with registered diagnosis of CJD at death, hospital discharge or notification, in the period 1987-2002, 1060 age-, sex- and residence-matched controls and 1340 randomly chosen population controls, were reclassified into one of six categories of hypothetical transmission risk level. For that purpose the following two attributes were used: non-disposable instruments involved; and highest assigned ad-hoc risk level for four tissues or anatomical structures contacting such instruments.
RESULTS: A total of 1170 different SP codes were reclassified as follows: 3.1% in the high-risk, 59.1% in the lower-risk, 24.4% in the lowest-risk, and 2.1% in the no-risk groups, with 11.3% procedures negatively defined by rubric as "other than..." being assigned to two spurious diluted-high and diluted-lower risk categories. The high-risk group mainly comprised neurosurgical (53%) and ophthalmic (39%) procedures. Sensitivity of neurosurgery and of ophthalmic surgery excluding neurosurgery, for the high- and diluted-high risk vs. other categories was 46% and 84%, while specificity was 98% and 95%, respectively. Sensitivity analysis based on these indices revealed that non-significant odds ratio effects of 1.4 and 1.3 for neurosurgery and ophthalmic surgery corresponded to statistically significant values of 5.1 after reclassification.
CONCLUSIONS: This classification might contribute to quantify effects masked by use of body-system SP-categories in case-control studies on sCJD transmission by surgery.

Entities:  

Mesh:

Year:  2006        PMID: 17031517     DOI: 10.1007/s10654-006-9044-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.

Authors:  I Zerr; J P Brandel; C Masullo; D Wientjens; R de Silva; M Zeidler; E Granieri; S Sampaolo; C van Duijn; N Delasnerie-Lauprêtre; R Will; S Poser
Journal:  J Clin Epidemiol       Date:  2000-07       Impact factor: 6.437

2.  Iatrogenic vCJD from surgical instruments.

Authors:  A Frosh; R Joyce; A Johnson
Journal:  BMJ       Date:  2001-06-30

3.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

4.  Ophthalmic surgery and Creutzfeldt-Jakob disease.

Authors:  P S-Juan; H J T Ward; R De Silva; R S G Knight; R G Will
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

5.  Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.

Authors:  D A Hilton; E Fathers; P Edwards; J W Ironside; J Zajicek
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

6.  A case control study of Creutzfeldt-Jakob disease: association with physical injuries.

Authors:  K Kondo; Y Kuroiwa
Journal:  Ann Neurol       Date:  1982-04       Impact factor: 10.422

Review 7.  Iatrogenic Creutzfeldt-Jakob disease at the millennium.

Authors:  P Brown; M Preece; J P Brandel; T Sato; L McShane; I Zerr; A Fletcher; R G Will; M Pocchiari; N R Cashman; J H d'Aignaux; L Cervenáková; J Fradkin; L B Schonberger; S J Collins
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

8.  Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.

Authors:  Markus Glatzel; Eugenio Abela; Manuela Maissen; Adriano Aguzzi
Journal:  N Engl J Med       Date:  2003-11-06       Impact factor: 91.245

9.  Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD).

Authors:  C M van Duijn; N Delasnerie-Lauprêtre; C Masullo; I Zerr; R de Silva; D P Wientjens; J P Brandel; T Weber; V Bonavita; M Zeidler; A Alpérovitch; S Poser; E Granieri; A Hofman; R G Will
Journal:  Lancet       Date:  1998-04-11       Impact factor: 79.321

10.  Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels.

Authors:  Alberto Rábano; Jesús de Pedro-Cuesta; Kåre Mølbak; Ake Siden; Miguel Calero; Henning Laursen
Journal:  BMC Public Health       Date:  2005-01-24       Impact factor: 3.295

View more
  3 in total

1.  Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions.

Authors:  Jesús de Pedro-Cuesta; Ignacio Mahillo-Fernández; Alberto Rábano; Miguel Calero; Mabel Cruz; Ake Siden; Henning Laursen; Gerhard Falkenhorst; Kåre Mølbak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-14       Impact factor: 10.154

2.  Towards an age-dependent transmission model of acquired and sporadic Creutzfeldt-Jakob disease.

Authors:  Jesús de Pedro-Cuesta; Ignacio Mahillo-Fernandez; Miguel Calero; Alberto Rábano; Mabel Cruz; Åke Siden; Pablo Martínez-Martín; Henning Laursen; María Ruiz-Tovar; Kåre Mølbak
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

3.  Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance.

Authors:  Mabel Cruz; Ignacio Mahillo-Fernandez; Alberto Rábano; Ake Siden; Miguel Calero; Henning Laursen; Kåre Mølbak; Javier Almazán; Jesus de Pedro-Cuesta
Journal:  Emerg Themes Epidemiol       Date:  2013-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.